These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 31129065)

  • 1. Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial.
    Al-Shahi Salman R; Minks DP; Mitra D; Rodrigues MA; Bhatnagar P; du Plessis JC; Joshi Y; Dennis MS; Murray GD; Newby DE; Sandercock PAG; Sprigg N; Stephen J; Sudlow CLM; Werring DJ; Whiteley WN; Wardlaw JM; White PM;
    Lancet Neurol; 2019 Jul; 18(7):643-652. PubMed ID: 31129065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial.
    RESTART Collaboration
    Lancet; 2019 Jun; 393(10191):2613-2623. PubMed ID: 31128924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial.
    Al-Shahi Salman R; Dennis MS; Murray GD; Innes K; Drever J; Dinsmore L; Williams C; White PM; Whiteley WN; Sandercock PAG; Sudlow CLM; Newby DE; Sprigg N; Werring DJ;
    Trials; 2018 Mar; 19(1):162. PubMed ID: 29506580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted imaging lesions and risk of recurrent stroke after intracerebral haemorrhage.
    Wiegertjes K; Dinsmore L; Drever J; Hutchison A; Stephen J; Valdés Hernández MC; Bhatnagar P; Minks DP; Rodrigues MA; Werring DJ; de Leeuw FE; Klijn CJ; Al-Shahi Salman R; White PM; Wardlaw JM
    J Neurol Neurosurg Psychiatry; 2021 Sep; 92(9):950-955. PubMed ID: 34103345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: statistical analysis plan for a randomised controlled trial.
    Al-Shahi Salman R; Murray GD; Dennis MS; Newby DE; Sandercock PAG; Sprigg N; Sudlow CLM; Werring DJ; White PM; Whiteley WN
    Trials; 2019 Mar; 20(1):183. PubMed ID: 30909946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial.
    Schreuder FHBM; van Nieuwenhuizen KM; Hofmeijer J; Vermeer SE; Kerkhoff H; Zock E; Luijckx GJ; Messchendorp GP; van Tuijl J; Bienfait HP; Booij SJ; van den Wijngaard IR; Remmers MJM; Schreuder AHCML; Dippel DW; Staals J; Brouwers PJAM; Wermer MJH; Coutinho JM; Kwa VIH; van Gelder IC; Schutgens REG; Zweedijk B; Algra A; van Dalen JW; Jaap Kappelle L; Rinkel GJE; van der Worp HB; Klijn CJM;
    Lancet Neurol; 2021 Nov; 20(11):907-916. PubMed ID: 34687635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.
    Baharoglu MI; Cordonnier C; Al-Shahi Salman R; de Gans K; Koopman MM; Brand A; Majoie CB; Beenen LF; Marquering HA; Vermeulen M; Nederkoorn PJ; de Haan RJ; Roos YB;
    Lancet; 2016 Jun; 387(10038):2605-2613. PubMed ID: 27178479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies.
    Wilson D; Ambler G; Lee KJ; Lim JS; Shiozawa M; Koga M; Li L; Lovelock C; Chabriat H; Hennerici M; Wong YK; Mak HKF; Prats-Sánchez L; Martínez-Domeño A; Inamura S; Yoshifuji K; Arsava EM; Horstmann S; Purrucker J; Lam BYK; Wong A; Kim YD; Song TJ; Schrooten M; Lemmens R; Eppinger S; Gattringer T; Uysal E; Tanriverdi Z; Bornstein NM; Assayag EB; Hallevi H; Tanaka J; Hara H; Coutts SB; Hert L; Polymeris A; Seiffge DJ; Lyrer P; Algra A; Kappelle J; Al-Shahi Salman R; Jäger HR; Lip GYH; Mattle HP; Panos LD; Mas JL; Legrand L; Karayiannis C; Phan T; Gunkel S; Christ N; Abrigo J; Leung T; Chu W; Chappell F; Makin S; Hayden D; Williams DJ; Kooi ME; van Dam-Nolen DHK; Barbato C; Browning S; Wiegertjes K; Tuladhar AM; Maaijwee N; Guevarra C; Yatawara C; Mendyk AM; Delmaire C; Köhler S; van Oostenbrugge R; Zhou Y; Xu C; Hilal S; Gyanwali B; Chen C; Lou M; Staals J; Bordet R; Kandiah N; de Leeuw FE; Simister R; van der Lugt A; Kelly PJ; Wardlaw JM; Soo Y; Fluri F; Srikanth V; Calvet D; Jung S; Kwa VIH; Engelter ST; Peters N; Smith EE; Yakushiji Y; Orken DN; Fazekas F; Thijs V; Heo JH; Mok V; Veltkamp R; Ay H; Imaizumi T; Gomez-Anson B; Lau KK; Jouvent E; Rothwell PM; Toyoda K; Bae HJ; Marti-Fabregas J; Werring DJ;
    Lancet Neurol; 2019 Jul; 18(7):653-665. PubMed ID: 31130428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage: Extended Follow-up of the RESTART Randomized Clinical Trial.
    Al-Shahi Salman R; Dennis MS; Sandercock PAG; Sudlow CLM; Wardlaw JM; Whiteley WN; Murray GD; Stephen J; Rodriguez A; Lewis S; Werring DJ; White PM;
    JAMA Neurol; 2021 Oct; 78(10):1179-1186. PubMed ID: 34477823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks of recurrent stroke and all serious vascular events after spontaneous intracerebral haemorrhage: pooled analyses of two population-based studies.
    Li L; Poon MTC; Samarasekera NE; Perry LA; Moullaali TJ; Rodrigues MA; Loan JJM; Stephen J; Lerpiniere C; Tuna MA; Gutnikov SA; Kuker W; Silver LE; Al-Shahi Salman R; Rothwell PM
    Lancet Neurol; 2021 Jun; 20(6):437-447. PubMed ID: 34022170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial.
    Desborough MJR; Al-Shahi Salman R; Stanworth SJ; Havard D; Woodhouse LJ; Craig J; Krishnan K; Brennan PM; Dineen RA; Coats TJ; Hepburn T; Bath PM; Sprigg N;
    Lancet Neurol; 2023 Jul; 22(7):557-567. PubMed ID: 37353276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet Therapy in Cerebral Small Vessel Disease.
    Bouasquevisque DS; Benavente OR; Shoamanesh A
    Curr Neurol Neurosci Rep; 2019 Jul; 19(9):61. PubMed ID: 31352655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
    Toyoda K; Uchiyama S; Yamaguchi T; Easton JD; Kimura K; Hoshino H; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K;
    Lancet Neurol; 2019 Jun; 18(6):539-548. PubMed ID: 31122494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study.
    Wilson D; Ambler G; Shakeshaft C; Brown MM; Charidimou A; Al-Shahi Salman R; Lip GYH; Cohen H; Banerjee G; Houlden H; White MJ; Yousry TA; Harkness K; Flossmann E; Smyth N; Shaw LJ; Warburton E; Muir KW; Jäger HR; Werring DJ;
    Lancet Neurol; 2018 Jun; 17(6):539-547. PubMed ID: 29778365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral microbleeds and asundexian in non-cardioembolic ischemic stroke: Secondary analyses of the PACIFIC-STROKE randomized trial.
    Balali P; Hart RG; Smith EE; Saad F; Colorado P; Lemmens R; De Marchis GM; Caso V; Xu L; Heenan L; Connolly SJ; Mundl H; Shoamanesh A
    Int J Stroke; 2024 Jun; 19(5):526-535. PubMed ID: 37950392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study.
    Huang Y; Cheng Y; Wu J; Li Y; Xu E; Hong Z; Li Z; Zhang W; Ding M; Gao X; Fan D; Zeng J; Wong K; Lu C; Xiao J; Yao C;
    Lancet Neurol; 2008 Jun; 7(6):494-9. PubMed ID: 18456558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study.
    Huang X; Cheripelli BK; Lloyd SM; Kalladka D; Moreton FC; Siddiqui A; Ford I; Muir KW
    Lancet Neurol; 2015 Apr; 14(4):368-76. PubMed ID: 25726502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet Treatment After Transient Ischemic Attack and Ischemic Stroke in Patients With Cerebral Microbleeds in 2 Large Cohorts and an Updated Systematic Review.
    Lau KK; Lovelock CE; Li L; Simoni M; Gutnikov S; Küker W; Mak HKF; Rothwell PM
    Stroke; 2018 Jun; 49(6):1434-1442. PubMed ID: 29748422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial.
    IST-3 collaborative group
    Lancet Neurol; 2015 May; 14(5):485-96. PubMed ID: 25819484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prehospital transdermal glyceryl trinitrate in patients with presumed acute stroke (MR ASAP): an ambulance-based, multicentre, randomised, open-label, blinded endpoint, phase 3 trial.
    van den Berg SA; Uniken Venema SM; Reinink H; Hofmeijer J; Schonewille WJ; Miedema I; Fransen PSS; O Pruissen DM; Raaijmakers TWM; van Dijk GW; de Leeuw FE; van Vliet JA; Kwa VIH; Kerkhoff H; van 't Net A; Boomars R; Siegers A; Lok T; Caminada K; Esteve Cuevas LM; Visser MC; Zwetsloot CP; Boomsma JMF; Schipper MH; van Eijkelenburg RPJ; Berkhemer OA; Nieboer D; Lingsma HF; Emmer BJ; van Oostenbrugge RJ; van der Lugt A; Roos YBWEM; Majoie CBLM; Dippel DWJ; Nederkoorn PJ; van der Worp HB;
    Lancet Neurol; 2022 Nov; 21(11):971-981. PubMed ID: 36058230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.